Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type ... (one marrow and spleen so selecting targe...)

Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type 2 Diabetes

Date:10/18/2007

one marrow and spleen, so selecting targets in these tissues is part of our strategy for developing effective drugs. We plan to move ISIS 388626 forward toward human proof-of-concept as rapidly as possible, and we look forward to continuing to populate our metabolic disease pipeline with drugs arising from our prolific research program."

ABOUT SGLT2 AND ISIS 388626

The sodium dependent glucose transporter type 2 (SGLT2) is substantially responsible for glucose re-absorption in the kidney. Decreasing SGLT2 function promotes glucose excretion to help reduce blood sugar levels, making it an attractive target for the treatment of diabetes. In preclinical studies, Isis has demonstrated in several animal species that ISIS 388626 and other antisense inhibitors of SGLT2 effectively reduce target mRNA levels, increase urinary glucose excretion and consequently lower blood glucose levels and HbA1c without causing dangerously low levels of blood sugar known as hypoglycemia. This is consistent with expectations based on human subjects who have mutations in the SGLT2 gene and have increased urine glucose levels but are otherwise asymptomatic. ISIS 388626 effectively and specifically inhibits the production of SGLT2 in the kidney tissue, without having any effect on a related gene product, SGLT1. In addition to being Isis' first second-generation antisense drug for a kidney target, ISIS 388626 is also unique due to its 12 nucleotide length rather than the more typical 18 - 21 nucleotide sequences that comprise Isis' other drugs. This attribute simplifies manufacturing and has the potential to substantially reduce related expenses. The short sequence may also contribute to ISIS 388626's unusually high potency; it is among the most potent antisense drugs Isis has yet evaluated in preclinical models.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The C
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Cancer drugs in development nearly doubled since 1995
3. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
4. Role of zinc in development
5. Particulate matter affects lung development
6. Fossil teeth and human development
7. High development costs hinder entry of cancer super drugs into the market
8. Fireflies help speed development of new drugs
9. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
10. New fertility drug development techniques by Organon
11. Biosensor chip to help drug development

Post Your Comments:

(Date:6/19/2013)... 2013 Kleritec, Inc. announced the addition ... http://www.kleritec.com . In the recent expansion Kleritec ... activities packages for pre-school and day care providers. The ... to aid teachers across the United States the ability ... , Included in the art and activities packages is ...

(Date:6/19/2013)... York, NY (PRWEB) June 19, 2013 Citi Bike ... There’s no way for Dr. David Perna to know for sure ... service, but he’s happy that they’ll have the option. In ... healthier lives—especially if it might also make it more convenient for ... Dr. Perna is the Director of Complimentary Alternative Medicine at Back ...

(Date:6/19/2013)... a major international study led by researchers at The ... therapy ibrutinib continues to show remarkable promise for the ... , The most recent interim findings of the 18-center ... New England Journal of Medicine . Previous interim findings ... Society of Hematology Annual Meeting and Exposition. , ...

(Date:6/19/2013)... as many emergency department visits if their primary care ... days a week, according to new research from child ... Hopkins University. , The new study was published online ... and will be presented at the AcademyHealth Annual Research ... understanding where primary care practices and medical home programs ...

(Date:6/19/2013)... Nearly 70 percent of Americans are on ... half take two, Mayo Clinic researchers say. Antibiotics, ... their study found. Twenty percent of patients are ... the findings, published online in the journal ... audio and video of Dr. Jennifer St. Sauver ...

Breaking Medicine News(10 mins):Health News:Kleritec Announces Addition of Educational Products. 2 Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2 Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3 Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2 Health News:Extended primary care office hours might help keep kids out of the emergency department 2 Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2

[0] Kleritec Announces Addition of Educational Products.[0] New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan [0] Ibrutinib continues strong showing against mantle cell lymphoma [0] Extended primary care office hours might help keep kids out of the emergency department [0] Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds

... , , MIAMI, Dec. ... creator of the immensely popular Dr. Siegal,s COOKIE DIET® weight-loss ... brand,s global distributor, this morning filed a lawsuit against reality ... made on her Twitter page on October 29, 2009. A ...

... SAN JOSE, Calif. , Dec. 29 The Coalition for ... advocacy, research support and awareness, even in a year plagued ... has no known cause, no FDA-approved treatment, and no cure. ... advancing the effort to build awareness of the disease throughout ...

... , Advisories Eased for Seven Water Bodies; ... State officials today released updated fish consumption advisories that ... had not previously been on the list, but also eases ... , The advisories were developed through an interagency partnership between ...

... , ... heels of its remarkable success in alcohol recovery, National Institute For Alcohol Recovery (NIFAR®) ... resolutions....(read more) , ... Gaithersburg, MD (PRWEB) December 29, 2009 -- On the heels of its remarkable success ...

... type 2 diabetes, prediabetes sooner, with no fasting, , TUESDAY, ... clinical guidelines, the American Diabetes Association is promoting a more ... diagnosis of type 2 diabetes and prediabetes. , Long used ... average blood sugar levels for the previous two to three ...

... , WASHINGTON, Dec. 29 ... Wellness Challenge -- three promotions spanning the next five ... their health goals in 2010. , "The goal of ... change their wellness habits, which can be difficult," says William ...

Cached Medicine News:Health News:Kim Kardashian Sued by Dr. Siegal's COOKIE DIET(R) Creator Dr. Sanford Siegal 2 Health News:Kim Kardashian Sued by Dr. Siegal's COOKIE DIET(R) Creator Dr. Sanford Siegal 3 Health News:Kim Kardashian Sued by Dr. Siegal's COOKIE DIET(R) Creator Dr. Sanford Siegal 4 Health News:Kim Kardashian Sued by Dr. Siegal's COOKIE DIET(R) Creator Dr. Sanford Siegal 5 Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 2 Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 3 Health News:Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn 4 Health News:Updated Fish Consumption Advisories Issued for 2010 2 Health News:Updated Fish Consumption Advisories Issued for 2010 3 Health News:Now Millions Suffering With Alcohol Addiction Can Get Breakthrough Recovery in Ultimate Privacy 2 Health News:Now Millions Suffering With Alcohol Addiction Can Get Breakthrough Recovery in Ultimate Privacy 3 Health News:New Guidelines Urge A1C Test for Diabetes Diagnosis 2 Health News:'Life...supplemented' Announces America's Wellness Challenge 2 Health News:'Life...supplemented' Announces America's Wellness Challenge 3

Kim Kardashian Sued by Dr. Siegal's COOKIE DIET(R) Creator Dr. Sanford Siegal Coalition for Pulmonary Fibrosis Celebrates Successes Despite Year of Economic Downturn Updated Fish Consumption Advisories Issued for 2010 Now Millions Suffering With Alcohol Addiction Can Get Breakthrough Recovery in Ultimate Privacy New Guidelines Urge A1C Test for Diabetes Diagnosis 'Life...supplemented' Announces America's Wellness Challenge

(Date:6/19/2013)... The Physician-Patient Alliance for Health & Safety recently released three ... urgently address this issue has been emphasized by The ... device alarm safety in hospitals." According to The Joint Commission ... there were 98 alarm related events reported, of which: ... resulted in permanent loss of function (13%) , 5 ...

(Date:6/19/2013)... NEW YORK , June 19, 2013 ... dedicated to finding a cure for brain cancer, today ... ) a grant to support the clinical investigation of ... a recurrent high grade glioma brain cancer (Grade 3 ... company developing novel treatments for advanced cancer, with an ...

(Date:6/19/2013)... Nektar Therapeutics (Nasdaq: NKTR ) ... (HAL) study for NKTR-181, a first-in-class, opioid analgesic ... This slow rate of entry is designed to reduce the ... to current opioid analgesics. 1 In the study data ... placebo in "drug liking" and "feeling high" scores and had ...

[0] Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals [0] Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer [0] Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence

... Study Showed 11 Percent Fewer RA Patients,Reported ... Therapy,Compared to Methotrexate Alone, BARCELONA, Spain, June ... one of the most common causes of,disability ... today show that,rheumatoid arthritis (RA) patients treated ...

... Influenza Conference, HIGH WYCOMBE, England, June 18, 2007 ... new flu vaccine has the,potential to protect against ... presented today by PepTcell, at the 2007,Options for ... Canada. , The pre-clinical results, which will be ...

Cached Medicine Technology:Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 2 Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 3 Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 4 Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 5 Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 6 Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 7 New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2 New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3 New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4

Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus

Kleinert-Kutz Single Skin Hook, Large...

Large....

Needle tip electrode, davol advantage electrosurgical attachments, 33cm (with extendible outer sheath), non-sterile. These products are supplied non-sterile and must be sterilized before use. Reusabl...

... The ARK-760A is an Auto ... and subjective refinement. Electronic elevation, ... measurement, unequalled accuracy and all ... made the Marco Automatic Refractors/Keratometer ...

Medicine Products:

Kleinert-Kutz Single Skin Hook Converse Skin Hook Needle Tip Electrode ARK-760A Automatic Refractor